Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Eton Pharmaceuticals, Inc. (ETON)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Eton Pharmaceuticals, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Eton Pharmaceuticals, Inc. since 2005.
The reporting company's ticker symbol is ETON. The reporting company's CIK number is 1710340.
The total value of stock buying since 2005 is $371,445.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-08-13||Brynjelsen Sean (President & CEO)||Buy||5,000||6.15||30,750|
|2019-08-09||Casamento Charles J (Director)||Buy||3,500||6.11||21,371|
|2019-05-21||Brynjelsen Sean (President & CEO)||Buy||8,600||7.96||68,430|
|2019-05-20||Brynjelsen Sean (President & CEO)||Buy||1,400||7.78||10,894|
|2018-11-15||Troutman William Wilson (CFO, Treasurer & Secretary)||Buy||5,000||6.00||30,000|
|2018-11-15||Brynjelsen Sean (President & CEO)||Buy||10,000||6.00||60,000|
|2018-11-15||Baum Mark L (Director)||Buy||10,000||6.00||60,000|
|2018-11-15||Maier Paul V (Director)||Buy||5,000||6.00||30,000|
|2018-11-15||Riedel Norbert G (Director)||Buy||5,000||6.00||30,000|
|2018-11-15||Casamento Charles J (Director)||Buy||5,000||6.00||30,000|
Insider trading activities including stock purchases, stock sales, and option exercises of ETON listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Eton Pharmaceuticals, Inc. (symbol ETON, CIK number 1710340) see the Securities and Exchange Commission (SEC) website.